Transforming growth factor beta 1 related gene polymorphisms in gestational hypertension and preeclampsia: A case-control candidate gene association study

Pregnancy Hypertension

Volumn 12, Issue , 2018, Pages 155-160

  Li, Xun ^a,b   Tan, Hongzhuan ^a   Chen, Mengshi ^a   Zhou, Shujin ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Liuyang Municipal Hospital of Maternal and Child Health   (China)

Author keywords

Endoglin; Gestational hypertension; Haplotype; Polymorphism; Preeclampsia; Transforming growth factor beta 1

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC MODEL; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; POPULATION BASED CASE CONTROL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TGFBETA1 GENE; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; GENETIC PREDISPOSITION; GENETICS; ODDS RATIO; PATHOPHYSIOLOGY; PHENOTYPE; PREGNANCY; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

PROTEIN SERINE THREONINE KINASE; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LOGISTIC MODELS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK FACTORS; YOUNG ADULT;

EID: 85034839159     PISSN: 22107789     EISSN: 22107797     Source Type: Journal    
DOI: 10.1016/j.preghy.2017.11.010     Document Type: Article

References (26)

1. Moser, M., Working group report on high blood pressure in pregnancy. J. Clin. Hypertens. 3:2 (2010), 75–88.
2. Massagué J., The transforming growth factor-beta family. Annu. Rev. Cell Biol., 6(1), 1990, 597.
3. Mantel, P.-Y., Schmidt-Weber, C.B., Transforming growth factor-beta: recent advances on its role in immune tolerance. 2011, Springer, Suppression and Regulation of Immune Responses, 303–338.
4. Dobaczewski, M., Chen, W., Frangogiannis, N.G., Transforming growth factor (TGF)-β signaling in cardiac remodeling. J. Mol. Cell. Cardiol. 51:4 (2011), 600–606.
5. Bierie, B., Moses, H.L., Transforming growth factor beta (TGF-β) and inflammation in cancer. Cytokine Growth Factor Rev., 21(1), 2010, 49.
6. Li, X., Shen, L., Tan, H., Polymorphisms and plasma level of transforming growth factor-beta 1 and risk for preeclampsia: a systematic review. PloS One, 9(5), 2014, e97230.
7. Lastres, P., Endoglin modulates cellular responses to TGF-β1. J. Cell Biol. 5 (1996), 1109–1121.
8. Levine, R.J., Lam, C., Qian, C., Yu, K.F., Maynard, S.E., Sachs, B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. Clin. Obstet. Gynecol. 48:2 (2007), 372–386.
9. Bell, M.J., Roberts, J.M., Founds, S.A., Jeyabalan, A., Terhorst, L., Conley, Y.P., Variation in endoglin pathway genes is associated with preeclampsia: a case–control candidate gene association study. BMC Pregnancy Childbirth, 13(1), 2013, 82.
10. Li, X., Tan, H., Zhou, S., Hu, S., Zhang, T., Li, Y., et al. Renin-angiotensin-aldosterone system gene polymorphisms in gestational hypertension and preeclampsia: a case-control gene-association study. Sci. Rep., 6, 2016, 38030.
11. Tranquilli, A.L., Dekker, G., Magee, L., Roberts, J., Sibai, B.M., Steyn, W., et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. Int. J. Women's Cardiovasc. Health 4:2 (2014), 97–104.
12. Gabriel, S., Ziaugra, L., Tabbaa, D., SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr. Protoc. Hum. Genet., 2009 2.12. 1-2. 6.
13. Xun, L., Tan, H., Zhou, S., Hu, S., Zhang, T., Li, Y., et al. Renin–angiotensin–aldosterone system gene polymorphisms in gestational hypertension and preeclampsia: a case–control gene-association study. Sci. Rep., 6, 2016.
14. Clausen, T., Djurovic, S., Reseland, J.E., Berg, K., Drevon, C.A., Henriksen, T., Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?. Placenta 23:5 (2002), 380–385 PubMed PMID: 12061853.
15. Lim, J.H., Kim, S.Y., Park, S.Y., Lee, M.H., Yang, J.H., Kim, M.Y., et al. Soluble endoglin and transforming growth factor-beta 1 in women who subsequently developed preeclampsia. Prenatal Diagnosis 29:5 (2009), 471–476 PubMed PMID: WOS:000266185500003.
16. Djurovic, S., Schjetlein, R., Wisloff, F., Haugen, G., Husby, H., Berg, K., Plasma concentrations of Lp(a) lipoprotein and TGF-beta1 are altered in preeclampsia. Clin. Genet. 52:5 (1997), 371–376 PubMed PMID: 9520129. Epub 1998/03/31. eng.
17. Naicker, T., Khedun, S.M., Moodley, J., Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia. J. Obstet. Gynaecol.: J. Inst. Obstet. Gynaecol. 22:3 (2002 May), 279–282 PubMed PMID: 12521499.
18. Madazli, R., Aydin, S., Uludag, S., Vildan, O., Tolun, N., Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet. et Gynecol. Scandinavica 82:9 (2003), 797–802 PubMed PMID: WOS:000184719900004.
19. Muy-Rivera, M., Sanchez, S.E., Vadachkoria, S., Qiu, C., Bazul, V., Williams, M.A., Transforming growth factor-beta1 (TGF-beta1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation. Am. J. Hypertens. 17:4 (2004), 334–338 PubMed PMID: 15062887.
20. Peracoli, M.T., Menegon, F.T., Borges, V.T., de Araujo Costa, R.A., Thomazini-Santos, I.A., Peracoli, J.C., Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia. J. Reprod. Immunol. 79:1 (2008), 79–84 PubMed PMID: 18805591.
21. Enquobahrie, D.A., Williams, M.A., Qiu, C., Woelk, G.B., Mahomed, K., Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women. J. Maternal-Fetal Neonatal Med: Off. J. the Eur. Assoc. Perinatal Med., Federat. Asia Oceania Perinatal Soc., Int. Soc. Perinatal Obstet. 17:5 (2005 May), 343–348 PubMed PMID: 16147848.
22. Grainger, D.J., Heathcote, K., Chiano, M., Snieder, H., Kemp, P.R., Metcalfe, J.C., et al. Genetic control of the circulating concentration of transforming growth factor type beta 1. PubMed PMID: 9887336. Epub 1999/01/15. eng Hum. Mol. Genet. 8:1 (1999), 93–97.
23. Feizollahzadeh, S., Taheripanah, R., Khani, M., Farokhi, B., Amani, D., Promoter region polymorphisms in the transforming growth factor beta-1 (TGFbeta1) gene and serum TGFbeta1 concentration in preeclamptic and control Iranian women. J. Reprod. Immunol. 94:2 (2012), 216–221 PubMed PMID: 22503347.
24. Aguilar-Duran, M., Salvador-Moysén, J., Galaviz-Hernandez, C., Vázquez-Alaniz, F., Sandoval-Carrillo, A.A., Velázquez-Hernández, N., et al. Haplotype analysis of TGF-β1 gene in a preeclamptic population of northern Mexico. Pregnancy Hypertens.: Int. J. Women's Cardiovasc. Health. 4:1 (2014), 14–18.
25. Zintzaras, E., Kitsios, G., Stefanidis, I., Response to endothelial nitric oxide synthase polymorphisms and susceptibility to hypertension: genotype versus haplotype analysis. Hypertension, 49(1), 2007 E2-E.
26. Morris, R.W., Kaplan, N.L., On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet. Epidemiol. 23:3 (2002), 221–233.